$AVO #Advanced Oncotherapy Hardman Co Research: Advanced Oncotherapy (AVO): Funded through to clinical events: AVO’s goal is to deliver an affordable and novel proton therapy (PT) system, called LIGHT, based on state-of-the-art technology… https://t.co/mQdt3ccMZh #equity #stocks https://t.co/pQFjidMoJ6